Pay in 4 interest-free payments of $5.45 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Cagrilintide for Different Populations Understanding how cagrilintide might work across diverse populations helps researchers and clinicians tailor approaches appropriately
March 22 Product: AbbVies Elahere Indication: Certain ovarian, fallopian tube and primary peritoneal cancers Friday, the FDA granted AbbVies Elahere full approval for patients with certain ovarian, fallopian tube and primary peritoneal cancers
It contains a bacteriostatic agent, so it is not for use in newborns and should be used with caution in pregnancy or where large cumulative volumes could be given, following the relevant warnings
Complete dosage chart for the 8mg/mL concentration The 8mg/mL vial requires a completely different set of calculations
